Preparation and preclinical evaluation of <sup>131</sup>I‐trastuzumab for breast cancer
Mythili Kameswaran(Tata Memorial Hospital), Ashutosh Dash(Bhabha Atomic Research Centre), Vikram Gota(Homi Bhabha National Institute), Sudeep Gupta(Homi Bhabha National Institute), Rajwardhan Ambade(Bhabha Atomic Research Centre)
Cited by 18
Related Papers
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
|Contemporary Clinical Trials|2016|162
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122